Pregnancy Changes Pituitary Opioid Peptides in Parallel With Oxytocin
Pregnancy and estrogen treatment altered pituitary met-enkephalin and dynorphin content in patterns paralleling oxytocin changes, suggesting opioid peptides regulate pregnancy hormone release.
Quick Facts
What This Study Found
Pregnancy and DES treatment altered pituitary met-enkephalin and dynorphin content in patterns paralleling oxytocin and vasopressin changes.
Key Numbers
How They Did This
Rat neurointermediate lobe tissue was analyzed during diestrus, after DES treatment, and at day 22 of pregnancy. Four peptides were measured for content, synthesis, and release.
Why This Research Matters
If opioid peptides regulate oxytocin release during pregnancy, this could affect labor onset, milk letdown, and maternal bonding. It also explains why opioid drugs can interfere with these processes.
The Bigger Picture
If opioid peptides regulate oxytocin during pregnancy, opioid medications could interfere with labor onset and breastfeeding. This connection is increasingly recognized in obstetric medicine.
What This Study Doesn't Tell Us
Animal study in rats. Pituitary peptide levels were measured but functional consequences not directly tested. DES (synthetic estrogen) effects may not perfectly mimic natural pregnancy hormones.
Questions This Raises
- ?Do opioid medications during pregnancy delay labor onset by suppressing oxytocin?
- ?Could opioid receptor modulators improve labor management?
Trust & Context
- Key Stat:
- Opioid-oxytocin parallel changes Met-enkephalin and dynorphin levels changed in patterns mirroring oxytocin during pregnancy and estrogen treatment
- Evidence Grade:
- Preliminary animal study measuring peptide content. Correlations do not prove functional regulation.
- Study Age:
- Published in 1991. Opioid-oxytocin interactions are now well-established in reproductive physiology.
- Original Title:
- Diethylstilbesterol- and pregnancy-induced changes in rat neurointermediate lobe oxytocin, arginine vasopressin, methionine enkephalin and dynorphin.
- Published In:
- Neuroendocrinology, 54(3), 185-91 (1991)
- Authors:
- Schriefer, J A
- Database ID:
- RPEP-00211
Evidence Hierarchy
Tests effects in animals (usually mice or rats), not humans.
What do these levels mean? →Frequently Asked Questions
How do opioid peptides affect oxytocin?
Opioid peptides in the pituitary can inhibit oxytocin release. During pregnancy, the balance between these systems changes to allow appropriate oxytocin levels for labor and breastfeeding.
Could opioid drugs delay labor?
Potentially. If opioid medications suppress oxytocin release, they could interfere with labor onset. This is one reason opioid use is carefully managed during pregnancy.
Read More on RethinkPeptides
Cite This Study
https://rethinkpeptides.com/research/RPEP-00211APA
Schriefer, J A. (1991). Diethylstilbesterol- and pregnancy-induced changes in rat neurointermediate lobe oxytocin, arginine vasopressin, methionine enkephalin and dynorphin.. Neuroendocrinology, 54(3), 185-91.
MLA
Schriefer, J A. "Diethylstilbesterol- and pregnancy-induced changes in rat neurointermediate lobe oxytocin, arginine vasopressin, methionine enkephalin and dynorphin.." Neuroendocrinology, 1991.
RethinkPeptides
RethinkPeptides Research Database. "Diethylstilbesterol- and pregnancy-induced changes in rat ne..." RPEP-00211. Retrieved from https://rethinkpeptides.com/research/schriefer-1991-diethylstilbesterol-and-pregnancyinduced-changes
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.